tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CLLS Stock Latest News

Cellectis Secures Final Tranche of EIB Credit Facility for CAR T-Cell Development
Company AnnouncementsCellectis Secures Final Tranche of EIB Credit Facility for CAR T-Cell Development
11d ago
6K
CLLS
Cellectis S.A. Reports Q3 2024 Financial Results and Updates
PremiumCompany Announcements
Cellectis S.A. Reports Q3 2024 Financial Results and Updates
2M ago
CLLS
Cellectis SA Advances CAR T-cell Therapy for Solid Tumors
PremiumCompany Announcements
Cellectis SA Advances CAR T-cell Therapy for Solid Tumors
2M ago
6K
CLLS
Cellectis price target lowered to $5 from $7 at Barclays
PremiumThe Fly
Cellectis price target lowered to $5 from $7 at Barclays
2M ago
CLLS
Cellectis reports Q3 EPS (22c), consensus (21c)
PremiumThe Fly
Cellectis reports Q3 EPS (22c), consensus (21c)
2M ago
CLLS
Cellectis S.A. Releases Interim Financial Results
PremiumCompany AnnouncementsCellectis S.A. Releases Interim Financial Results
2M ago
6K
CLLS
CLLS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CLLS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CLLS
Cellectis SA to Unveil Q3 2024 Financial Results
Premium
Company Announcements
Cellectis SA to Unveil Q3 2024 Financial Results
2M ago
6K
CLLS
Cellectis Presents New Gene-Editing Breakthroughs
PremiumCompany Announcements
Cellectis Presents New Gene-Editing Breakthroughs
2M ago
6K
CLLS
Cellectis’ Breakthrough in TNBC Therapy
PremiumCompany Announcements
Cellectis’ Breakthrough in TNBC Therapy
4M ago
6K
CLLS
Cellectis publishes pre-clinical evidence MUC1 CAR T-cells reducing certain BC
PremiumThe Fly
Cellectis publishes pre-clinical evidence MUC1 CAR T-cells reducing certain BC
4M ago
CLLS
Cellectis Reveals Promising Cancer Therapy Breakthrough
PremiumCompany Announcements
Cellectis Reveals Promising Cancer Therapy Breakthrough
4M ago
6K
CLLS
Cellectis Boosts Leadership with New CMO
PremiumCompany AnnouncementsCellectis Boosts Leadership with New CMO
5M ago
6K
CLLS
Cellectis S.A. Unveils Mid-Year Financial Report
Premium
Company Announcements
Cellectis S.A. Unveils Mid-Year Financial Report
5M ago
6K
CLLS
Cellectis granted orphan drug designation for CLLS52
Premium
The Fly
Cellectis granted orphan drug designation for CLLS52
5M ago
CLLS
Cellectis Gains FDA Orphan Drug Status for ALL Therapy
PremiumCompany Announcements
Cellectis Gains FDA Orphan Drug Status for ALL Therapy
5M ago
6K
CLLS
CLLS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CLLS Earnings this Week: How Will it Perform?
5M ago
CLLS
Cellectis Gains FDA Designations for Leukemia Therapy
PremiumCompany Announcements
Cellectis Gains FDA Designations for Leukemia Therapy
5M ago
6K
CLLS
FDA grants Cellectis’ UCART22 ODD and RPDD status for ALL treatment
PremiumThe Fly
FDA grants Cellectis’ UCART22 ODD and RPDD status for ALL treatment
5M ago
CLLS
Cellectis treatment of acute lymphoblastic leukemia granted orphan designation
PremiumThe FlyCellectis treatment of acute lymphoblastic leukemia granted orphan designation
5M ago
CLLS
Cellectis Shareholders Approve Key Resolutions
Premium
Company Announcements
Cellectis Shareholders Approve Key Resolutions
6M ago
6K
CLLS
Cellectis Shareholders Support Management’s Vision
Premium
Company Announcements
Cellectis Shareholders Support Management’s Vision
6M ago
6K
CLLS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >